Author

Ben Kelly

Nationwide Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Afrooz RashnonejadiD· 1 shared Allison M. BradburyiD· 1 shared Burçak ÖzeşiD· 1 shared Colin T. MaguireiD· 1 shared Devi Jaganathan· 1 shared Ebru Erzurumluoğlu GökalpiD· 1 shared Eleonora Silvana D'AmbrosioiD· 1 shared Genesis Snyder· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Afrooz RashnonejadORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

REMEDY: REpair of heterozygous Mutations independent of Exogenous Donor template with high efficiency using allele specific CRISPR targeting and HDR enhancers

Yasemin Sezgin, Genesis Snyder, Noushin Saljoughian, Colin T. Maguire, Ebru Erzurumluoğlu Gökalp, Devi Jaganathan, Eleonora Silvana D'Ambrosio, Burçak Özeş, Gregory L. Wheeler, Ben Kelly, Mark E. Hester, Zarife Sahenk, Sriram Vaidyanathan, Afrooz Rashnonejad, Jerry R. Mendell, , Meisam Naeimi Kararoudi

REMEDY enables efficient repair of heterozygous mutations in human and mouse cells without exogenous donor DNA by using CRISPR-induced DSBs and HDR enhancers.

bioRxiv · May 29, 2025 · PreprintGenetics